News

      September 21, 2020 Event

      24th Sept 2020 – Oblique Therapeutics

      is delighted to be invited to speak at “Biopharma Conclave 2020”.

      Read more

      September 14, 2020 Event

      Oblique Therapeutics is honored to participate

      as speaker to the 2nd Edition RAS-Targeted Drug Development Congress 15th September 2020.

      Read more

      June 29, 2020 News

      Oblique Therapeutics and Targovax enter collaboration

      to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms.

      Read more

      June 11, 2020 News

      Oblique Therapeutics AB has identified

      a potentially important epitope for generation of SARS-CoV-2 antibodies.

      Read more

      June 4, 2020 News

      General Meeting 2020

      Oblique Therapeutics AB – Notice to the annual general meeting 2020.

      Read more

      November 27, 2019 News

      Notice convening the Extraordinary

      General Meeting on December 6 at 2pm.

      Read more

      October 24, 2019 Event

      Oblique will be presenting at the RAS-Targeted

      Drug Discovery Europe Summit in February.

      Read more

      October 10, 2019 News

      Oblique Therapeutics is on EU-Startups top 10 list

      -“10 European biotech startups to look out for in 2019 and beyond”.

      Read more

      July 17, 2019 News

      We are proud to have been recognised

      by StartUp City Magazine as one of the most promising European Biotech startups in 2019!

      Read more
      1 2 3